Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROXIMUS: Oxcarbazepine in MS
NCT02104661Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Oct 2014
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxcarbazepine in multiple sclerosis (MS), sponsored by Queen Mary University of London. Started Oct 2014; status: completed.
02
Drugs
oxcarbazepine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02104661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104661.